Total Clarity Wealth Management, Inc. Infinity Pharmaceuticals, Inc. Transaction History

Total Clarity Wealth Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	BUY	$0.49 - $1.2 $1,470 - $3,600	3,000 New	3,000 $2,000
Q1 2022 Apr 29, 2022	SELL	$0.85 - $2.4 $2,550 - $7,200	-3,000 Closed	0 $0
Q4 2021 Feb 03, 2022	BUY	$1.86 - $3.36 $1,860 - $3,360	1,000 Added 50.0%	3,000 $7,000
Q3 2021 Oct 21, 2021	BUY	$1.52 - $3.82 $3,040 - $7,640	2,000 New	2,000 $7,000
Q2 2021 Jul 26, 2021	SELL	$2.66 - $3.47 $5,320 - $6,940	-2,000 Closed	0 $0
Q1 2021 May 05, 2021	BUY	$1.98 - $5.36 $3,960 - $10,720	2,000 New	2,000 $6,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Total Clarity Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Total Clarity Wealth Management, Inc. with notifications on news.